Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01189552 · ClinicalTrials.gov registry record · NA
Depression Treatment for Low Income Substance Users
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 263
- Enrollment target
NCT01189552: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT01189552 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 263 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01189552, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
Study Summary
The objective of the current study is to evaluate the effects of a brief, behavioral activation treatment (the Life Enhancement Treatment for Substance Use; LET'S ACT) on long term outcomes of substance use, HIV risk behaviors and mechanisms of treatment response (depressive symptoms, environmental reward, behavioral activation).
Primary Outcome
Urine Screen and Timeline Followback
Interventions
- BEHAVIORAL Nondirective Therapy (NDT)
- BEHAVIORAL LETS ACT Behavioral Activation Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT01189552 record still lists
NCT01189552 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Nondirective Therapy (NDT) is the first listed.
NCT01189552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01189552 about?
NCT01189552 is a clinical study titled "Depression Treatment for Low Income Substance Users". The objective of the current study is to evaluate the effects of a brief, behavioral activation treatment (the Life Enhancement Treatment for Substance Use; LET'S ACT) on long term outcomes of substance use, HIV risk behaviors and mechanisms of treatment response (depressive symptoms, environmental ...
What is the current status of trial NCT01189552?
This trial is currently completed. It is a NA study. The enrollment target is 263 participants. The study started on 2010-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01189552?
The interventions under investigation include: Nondirective Therapy (NDT) (BEHAVIORAL), LETS ACT Behavioral Activation Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01189552?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01189552's enrollment target sits among peer trials
263 396th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia